South Korea Proton Therapy Market Forecast to 2022 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "South Korea Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022" report to their offering.

South Korea Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy Market.

South Korea proton therapy market is anticipated to almost three-fold during the period 2016 - 2022. The number of patients treated with Proton Therapy in South Korea is very low whereas; the potential candidates for proton therapy are huge. Unfortunately, the access to proton therapy is limited for a vast population, owing to a low number of proton therapy centers. Hence, many research institutions and hospitals have now started investing in proton therapy to make it more accessible to patients.

Key Topics Covered:

1. Executive Summary

2. South Korea Proton Therapy Market Analysis

3. South Korea - List of Proton Therapy Centers, Start of Treatment, Patient Treated

4. South Korea - Number of Patients Treated at Proton Therapy Centers

5. Current Radiation Therapies

6. Components of a Standard Proton Therapy Center

7. Proton Therapy - Driving Factors

8. Proton Therapy - Challenges

For more information about this report visit http://www.researchandmarkets.com/research/5hbpr8/south_korea

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Nuclear Medicine and Radiopharmacology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Nuclear Medicine and Radiopharmacology